Humana Inc.
HUM
Clasificación en acciones
#491
Humana Inc., a prominent health and well-being enterprise, operates across the... Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Precio por acción
$414.60
Última sincronización: 2026-10-19
Capitalización bursátil
$49.79B
Cambio (1 día)
0.18%
Cambio (1 año)
45.99%
País
US
Comercio Humana Inc. (HUM)
Categoría
Healthcare
Ratio P/E de Humana Inc. (HUM)
Ratio P/E al October 2026 TTM: 40.15
Según los últimos informes financieros y el precio de las acciones de Humana Inc., el P/E actual (TTM) de la empresa es 40.15. Al final de 2023, la empresa tenía un P/E de 22.78.
Historial del ratio P/E de Humana Inc. desde 2000 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 40.15 | 58.44% |
| 2024 | 25.34 | 11.24% |
| 2023 | 22.78 | -1.27% |
| 2022 | 23.08 | 13.38% |
| 2021 | 20.35 | 26.35% |
| 2020 | 16.11 | -11.25% |
| 2019 | 18.15 | -22.44% |
| 2018 | 23.40 | 59.83% |
| 2017 | 14.64 | -70.50% |
| 2016 | 49.64 | 137.40% |
| 2015 | 20.91 | 8.29% |
| 2014 | 19.31 | 46.20% |
| 2013 | 13.21 | 45.62% |
| 2012 | 9.07 | -11.20% |
| 2011 | 10.21 | 22.21% |
| 2010 | 8.36 | 18.28% |
| 2009 | 7.07 | -26.63% |
| 2008 | 9.63 | -36.11% |
| 2007 | 15.07 | -19.06% |
| 2006 | 18.62 | -34.53% |
| 2005 | 28.45 | 67.66% |
| 2004 | 16.97 | 4.69% |
| 2003 | 16.21 | 37.75% |
| 2002 | 11.76 | -29.15% |
| 2001 | 16.61 | -41.20% |
| 2000 | 28.24 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 22.58 | -43.76% |
US
|
|
| 23.60 | -41.22% |
US
|
|
| 19.03 | -52.61% |
US
|
|
| 11.94 | -70.26% |
US
|
|
| - | - |
US
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.